These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38574443)
1. Global distribution of colistin- and carbapenem-resistant Citrobacter freundii. Monte DFM; de Oliveira CJB Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116248. PubMed ID: 38574443 [No Abstract] [Full Text] [Related]
2. Circulation of Venditti C; Fortini D; Villa L; Vulcano A; D'Arezzo S; Capone A; Petrosillo N; Nisii C; Carattoli A; Di Caro A Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559268 [TBL] [Abstract][Full Text] [Related]
3. Detection and spread of carbapenem-resistant Citrobacter freundii in a teaching hospital in China. Chen S; Hu F; Liu Y; Zhu D; Wang H; Zhang Y Am J Infect Control; 2011 Nov; 39(9):e55-60. PubMed ID: 21705111 [TBL] [Abstract][Full Text] [Related]
4. Detection of KPC-2-producing Citrobacter freundii isolates in Spain. Gómez-Gil MR; Paño-Pardo JR; Romero-Gómez MP; Gasior M; Lorenzo M; Quiles I; Mingorance J J Antimicrob Chemother; 2010 Dec; 65(12):2695-7. PubMed ID: 20851814 [No Abstract] [Full Text] [Related]
5. Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. Rasheed JK; Biddle JW; Anderson KF; Washer L; Chenoweth C; Perrin J; Newton DW; Patel JB J Clin Microbiol; 2008 Jun; 46(6):2066-9. PubMed ID: 18385437 [TBL] [Abstract][Full Text] [Related]
6. Emergence of a multidrug-resistant Citrobacter freundii ST8 harboring an unusual VIM-4 gene cassette in Poland. Majewski P; Wieczorek P; Łapuć I; Ojdana D; Sieńko A; Sacha P; Kłoczko J; Tryniszewska E Int J Infect Dis; 2017 Aug; 61():70-73. PubMed ID: 28602727 [TBL] [Abstract][Full Text] [Related]
7. Genetically unrelated multidrug- and carbapenem-resistant Citrobacter freundii detected in outpatients admitted to a Portuguese hospital. Santos C; Ramalheira E; Da Silva G; Mendo S J Glob Antimicrob Resist; 2017 Mar; 8():18-22. PubMed ID: 27915087 [TBL] [Abstract][Full Text] [Related]
8. First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany. Weile J; Rahmig H; Gfröer S; Schroeppel K; Knabbe C; Susa M Scand J Infect Dis; 2007; 39(3):264-6. PubMed ID: 17366062 [TBL] [Abstract][Full Text] [Related]
9. A sophisticated virulence repertoire and colistin resistance of Citrobacter freundii ST150 from a patient with sepsis admitted to ICU in a tertiary care hospital in Uganda, East Africa: Insight from genomic and molecular docking analyses. Maghembe RS; Magulye MAK; Eilu E; Sekyanzi S; Makaranga A; Mwesigwa S; Katagirya E Infect Genet Evol; 2024 Jun; 120():105591. PubMed ID: 38604286 [TBL] [Abstract][Full Text] [Related]
10. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. Zhang R; Yang L; Cai JC; Zhou HW; Chen GX J Med Microbiol; 2008 Mar; 57(Pt 3):332-337. PubMed ID: 18287296 [TBL] [Abstract][Full Text] [Related]
11. Coexistence of multiple antimicrobial-resistance genes in a carbapenem-resistant Citrobacter freundii clinical isolate from China. Pan J; Hu L; Yu F; Chen C; Zhang X J Med Microbiol; 2010 May; 59(Pt 5):622-623. PubMed ID: 20110384 [No Abstract] [Full Text] [Related]
12. Coexistence of NDM-1-producing Escherichia coli and Citrobacter freundii in the same patient. Zhu B; Ying C; Xu H; Ying J J Glob Antimicrob Resist; 2018 Dec; 15():79-81. PubMed ID: 29727717 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of decreased susceptibility to carbapenems among Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii and investigation of carbapenemases. Lee HK; Park YJ; Kim JY; Chang E; Cho SG; Chae HS; Kang CS Diagn Microbiol Infect Dis; 2005 Aug; 52(4):331-6. PubMed ID: 15994052 [TBL] [Abstract][Full Text] [Related]
14. Cefotaxime-resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan. Liu CP; Weng LC; Tseng HK; Wang NY; Lee CM J Infect; 2007 Oct; 55(4):363-8. PubMed ID: 17572502 [TBL] [Abstract][Full Text] [Related]
15. Mohanty S; Gaind R Indian J Med Microbiol; 2016; 34(4):558-560. PubMed ID: 27934845 [No Abstract] [Full Text] [Related]
16. Emergence of the colistin resistance gene mcr-1 in Citrobacter freundii. Li XP; Fang LX; Jiang P; Pan D; Xia J; Liao XP; Liu YH; Sun J Int J Antimicrob Agents; 2017 Jun; 49(6):786-787. PubMed ID: 28433744 [No Abstract] [Full Text] [Related]
17. A small outbreak of third generation cephem-resistant Citrobacter freundii infection on a surgical ward. Nada T; Baba H; Kawamura K; Ohkura T; Torii K; Ohta M Jpn J Infect Dis; 2004 Aug; 57(4):181-2. PubMed ID: 15329453 [No Abstract] [Full Text] [Related]
18. In vitro and in vivo activities of tigecycline-colistin combination therapies against carbapenem-resistant Enterobacteriaceae. Betts JW; Phee LM; Hornsey M; Woodford N; Wareham DW Antimicrob Agents Chemother; 2014 Jun; 58(6):3541-6. PubMed ID: 24687491 [TBL] [Abstract][Full Text] [Related]
19. KHM-1, a novel plasmid-mediated metallo-beta-lactamase from a Citrobacter freundii clinical isolate. Sekiguchi J; Morita K; Kitao T; Watanabe N; Okazaki M; Miyoshi-Akiyama T; Kanamori M; Kirikae T Antimicrob Agents Chemother; 2008 Nov; 52(11):4194-7. PubMed ID: 18765691 [TBL] [Abstract][Full Text] [Related]